{"id":"donepezil-drug-treatment","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"10-15","effect":"Diarrhea"},{"rate":"5-10","effect":"Vomiting"},{"rate":"5-10","effect":"Muscle cramps"},{"rate":"5-10","effect":"Fatigue"},{"rate":"5-10","effect":"Insomnia"},{"rate":"2-3","effect":"Syncope"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Donepezil is a reversible inhibitor of the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine. By inhibiting this enzyme, donepezil increases acetylcholine concentration in the synaptic cleft, enhancing cholinergic neurotransmission. This mechanism helps improve memory, attention, and cognitive function in patients with Alzheimer's disease, particularly in early to moderate stages.","oneSentence":"Donepezil inhibits acetylcholinesterase, increasing acetylcholine levels in the brain to improve cognitive function in Alzheimer's disease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:49.114Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mild to moderate Alzheimer's disease"},{"name":"Mild cognitive impairment"}]},"trialDetails":[{"nctId":"NCT04661280","phase":"PHASE3","title":"Donepezil Versus Non-drug Treatment in Alzheimer's Disease.","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-02-10","conditions":"Alzheimer Disease, Early Onset","enrollment":240},{"nctId":"NCT07351773","phase":"NA","title":"Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease","status":"COMPLETED","sponsor":"Taizhou Second People's Hospital","startDate":"2025-01-26","conditions":"Alzheimer's Disease(AD), Cognitive Dysfunction","enrollment":40},{"nctId":"NCT07208344","phase":"EARLY_PHASE1","title":"Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2025-07-31","conditions":"Alzheimer Disease (AD)","enrollment":30},{"nctId":"NCT05078944","phase":"NA","title":"Progress of Mild Alzheimer's Disease in Participants on Acupuncture Versus Sham Acupuncture","status":"COMPLETED","sponsor":"Shanghai Institute of Acupuncture, Moxibustion and Meridian","startDate":"2022-06-30","conditions":"Alzheimer Disease 1","enrollment":160},{"nctId":"NCT05042102","phase":"PHASE2","title":"Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)","status":"RECRUITING","sponsor":"VA Connecticut Healthcare System","startDate":"2022-08-08","conditions":"Alcohol Use Disorder","enrollment":160},{"nctId":"NCT07152418","phase":"","title":"Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Alzheimer Disease (AD), Alzheimer Dementia, Mild Cognitive Impairment (MCI)","enrollment":120},{"nctId":"NCT02670161","phase":"PHASE4","title":"Quality Improvement and Practice Based Research in Neurology Using the EMR","status":"ENROLLING_BY_INVITATION","sponsor":"Endeavor Health","startDate":"2016-05","conditions":"Brain Tumors, Epilepsy, Migraine","enrollment":3300},{"nctId":"NCT07094438","phase":"PHASE1","title":"Study Safety and Efficacy of Deep Brain Stimulation (DBS) and Cervical Deep Lymphoid-venous Anastomosis (LVA) in Alzheimer's Disease","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2025-01-01","conditions":"Alzheimer Disease","enrollment":98},{"nctId":"NCT06871839","phase":"","title":"The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease","status":"RECRUITING","sponsor":"Cuibai Wei，Clinical Professor","startDate":"2025-03-10","conditions":"Alzheimer's Disease, Lecanemab, Functional Magnetic Resonance Imaging","enrollment":120},{"nctId":"NCT07060391","phase":"PHASE3","title":"A Prospective Multicenter RCT Study of Deep Jugular Lymphovenous Anastomosis in the Treatment of Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2025-07-31","conditions":"Alzheimer's Disease","enrollment":186},{"nctId":"NCT04117178","phase":"PHASE4","title":"Monitoring Anti-Dementia Drugs by Serum Levels","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2020-02-04","conditions":"Dementia, Dementia With Lewy Bodies, Dementia in Parkinsons Disease","enrollment":132},{"nctId":"NCT06774261","phase":"PHASE1","title":"Phenserine on the Alzheimer's Treatment Horizon, Study 1","status":"NOT_YET_RECRUITING","sponsor":"Helse Stavanger HF","startDate":"2025-02-01","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":16},{"nctId":"NCT05801380","phase":"","title":"Monitoring Drug Efficacy in Patients with Alzheimer's Disease","status":"RECRUITING","sponsor":"University of the Philippines","startDate":"2022-02-14","conditions":"Alzheimer Disease","enrollment":60},{"nctId":"NCT02635750","phase":"PHASE1","title":"Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2016-01-15","conditions":"Healthy","enrollment":32},{"nctId":"NCT02487082","phase":"PHASE2","title":"Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders","status":"TERMINATED","sponsor":"Stony Brook University","startDate":"2015-06","conditions":"Autism Spectrum Disorder","enrollment":12},{"nctId":"NCT06393413","phase":"EARLY_PHASE1","title":"To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer 's Disease","status":"COMPLETED","sponsor":"Changchun University of Chinese Medicine","startDate":"2022-12-01","conditions":"Ensure the Legality and Compliance of the Testing Process","enrollment":62},{"nctId":"NCT06373094","phase":"PHASE1","title":"A Single Dose Escalation Study of HHT201 in Healthy Subjects","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Synergy Pharmaceutical Sciences Co., Ltd.","startDate":"2024-06-01","conditions":"Alzheimer Disease","enrollment":64},{"nctId":"NCT05976152","phase":"PHASE3","title":"Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER)","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-04","conditions":"Stroke, Post-stroke Cognitive Impairment (PSCI)","enrollment":3200},{"nctId":"NCT04507438","phase":"PHASE2","title":"The Effect of Donepezil on Glycemic Control in Type II Diabetics","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2019-07-12","conditions":"Diabetes Mellitus, Type 2","enrollment":7},{"nctId":"NCT03454646","phase":"PHASE4","title":"Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2024-06-01","conditions":"Alzheimer Disease, Cholinesterase Inhibitors","enrollment":1205},{"nctId":"NCT05811000","phase":"PHASE2, PHASE3","title":"A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease","status":"UNKNOWN","sponsor":"Mediforum Ltd., Co.","startDate":"2020-11-27","conditions":"Mild Alzheimer Disease","enrollment":312},{"nctId":"NCT05641480","phase":"NA","title":"Technical R&D and Demonstration of Intelligent Medical Care in Alzheimer's Disease's Management","status":"UNKNOWN","sponsor":"Shaanxi Hospital of Traditional Chinese Medicine","startDate":"2022-06-03","conditions":"Alzheimer Disease, Subjective Cognitive Decline, Mild Cognitive Impairment","enrollment":150},{"nctId":"NCT05538507","phase":"PHASE2","title":"Efficacy of Chinese Traditional Medicine \"Smart Soup\" in Cognition and Behavior Regulation in Alzheimer's Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2022-06-01","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":180},{"nctId":"NCT03954613","phase":"PHASE4","title":"Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease","status":"UNKNOWN","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2020-10-15","conditions":"Alzheimer Disease, Cognitive Change","enrollment":198},{"nctId":"NCT04732182","phase":"NA","title":"Telerehabilitation Alzheimer's Disease Feasibility (TADF)","status":"UNKNOWN","sponsor":"Bright Cloud International Corp","startDate":"2022-02-16","conditions":"Alzheimer Disease, Healthy Aging","enrollment":14},{"nctId":"NCT04731311","phase":"NA","title":"Telerehabilitation Alzheimer's Disease Usability (TADU)","status":"COMPLETED","sponsor":"Bright Cloud International Corp","startDate":"2021-07-29","conditions":"Alzheimer Disease, Healthy Aging","enrollment":4},{"nctId":"NCT05321680","phase":"NA","title":"Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD)","status":"COMPLETED","sponsor":"Centro Hospitalar De São João, E.P.E.","startDate":"2021-03-01","conditions":"Dementia","enrollment":16},{"nctId":"NCT05102045","phase":"NA","title":"The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2016-09-01","conditions":"Alzheimer Disease","enrollment":27},{"nctId":"NCT03221894","phase":"","title":"A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease","status":"COMPLETED","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2017-07-15","conditions":"Alzheimer Disease","enrollment":120},{"nctId":"NCT03073876","phase":"PHASE4","title":"Detecting an Early Response to Donepezil With Measures of Visual Attention","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2005-12-01","conditions":"Alzheimer Disease","enrollment":25},{"nctId":"NCT02573519","phase":"NA","title":"Gastrointestinal Motility Among Diabetes Patients","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2015-10","conditions":"Diabetic Autonomic Neuropathy, Gastrointestinal Motility Disorder, Diabetes Mellitus","enrollment":40},{"nctId":"NCT04134416","phase":"PHASE3","title":"Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke Aphasia","status":"COMPLETED","sponsor":"University of Malaga","startDate":"2019-01-08","conditions":"Aphasia, Stroke","enrollment":20},{"nctId":"NCT03932916","phase":"PHASE1","title":"Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects","status":"COMPLETED","sponsor":"Shanghai Synergy Pharmaceutical Sciences Co., Ltd.","startDate":"2019-07-02","conditions":"AD","enrollment":38},{"nctId":"NCT03184467","phase":"PHASE2","title":"Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients","status":"COMPLETED","sponsor":"GemVax & Kael","startDate":"2017-09-05","conditions":"Alzheimer Disease","enrollment":96},{"nctId":"NCT02711683","phase":"","title":"DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil","status":"COMPLETED","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2016-03","conditions":"Alzheimer's Disease","enrollment":92},{"nctId":"NCT02918266","phase":"PHASE1","title":"TAK-071 Scopolamine-Induced Cognitive Impairment Study","status":"TERMINATED","sponsor":"Takeda","startDate":"2016-11-21","conditions":"Healthy Volunteers","enrollment":18},{"nctId":"NCT02769065","phase":"PHASE1","title":"Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants","status":"TERMINATED","sponsor":"Takeda","startDate":"2016-05-05","conditions":"Alzheimer Disease, Healthy Volunteers","enrollment":179},{"nctId":"NCT02450786","phase":"PHASE2","title":"Effect of Donepezil on Cognition in Parkinson's Disease With Mild Cognitive Impairment (PD-MCI)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2015-06","conditions":"Parkinson's Disease","enrollment":80},{"nctId":"NCT00874939","phase":"PHASE1","title":"A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-04-06","conditions":"Alzheimer's Disease, Dementia","enrollment":4},{"nctId":"NCT00768261","phase":"PHASE4","title":"Corticolimbic Degeneration and Treatment of Dementia","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2004-11","conditions":"Dementia","enrollment":39},{"nctId":"NCT02331771","phase":"NA","title":"Donepezil Memory Preservation Post ECT","status":"TERMINATED","sponsor":"Porter Adventist Hospital","startDate":"2015-09-24","conditions":"Memory Impairment","enrollment":12},{"nctId":"NCT03569579","phase":"PHASE1","title":"CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2018-04-16","conditions":"Central Nervous System Diseases","enrollment":20},{"nctId":"NCT02222727","phase":"PHASE2","title":"Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage","status":"TERMINATED","sponsor":"St George's, University of London","startDate":"2014-01","conditions":"Aneurysmal Subarachnoid Hemorrhage, Delayed Neurological Deficit, Delayed Cerebral Ischemia","enrollment":19},{"nctId":"NCT01677754","phase":"PHASE2","title":"A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2012-10-24","conditions":"Alzheimer's Disease","enrollment":542},{"nctId":"NCT02035982","phase":"PHASE3","title":"Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2010-07","conditions":"Alzheimer's Disease, Dementia","enrollment":40},{"nctId":"NCT02051335","phase":"PHASE1","title":"Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-01","conditions":"Memory Impairment, Alzheimer's Disease","enrollment":27},{"nctId":"NCT02648906","phase":"PHASE4","title":"A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients","status":"UNKNOWN","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2015-07","conditions":"Alzheimer Disease","enrollment":128},{"nctId":"NCT02696512","phase":"PHASE1, PHASE2","title":"A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness","status":"UNKNOWN","sponsor":"International Brain Research Foundation","startDate":"2016-03","conditions":"Brain Injury","enrollment":30},{"nctId":"NCT01266525","phase":"PHASE2","title":"Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-02","conditions":"Dementia Alzheimer's Type","enrollment":291},{"nctId":"NCT01181310","phase":"PHASE1","title":"Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-06","conditions":"Dementia","enrollment":31},{"nctId":"NCT02055703","phase":"PHASE1","title":"A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2014-01","conditions":"Healthy Subjects","enrollment":195},{"nctId":"NCT01822951","phase":"PHASE4","title":"Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)","status":"WITHDRAWN","sponsor":"Ever Neuro Pharma GmbH","startDate":"","conditions":"Alzheimer Disease","enrollment":""},{"nctId":"NCT00887601","phase":"PHASE1","title":"BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-08","conditions":"Dementia","enrollment":32},{"nctId":"NCT01487395","phase":"PHASE1","title":"Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2011-12","conditions":"Alzheimer Disease, Battery","enrollment":30},{"nctId":"NCT02178124","phase":"PHASE1","title":"A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.","status":"COMPLETED","sponsor":"Icure Pharmaceutical Inc.","startDate":"2014-07","conditions":"Alzheimer Disease","enrollment":24},{"nctId":"NCT00423228","phase":"NA","title":"Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease","status":"COMPLETED","sponsor":"Debiopharm International SA","startDate":"2007-02","conditions":"Moderate Alzheimer's Disease","enrollment":228},{"nctId":"NCT01451749","phase":"PHASE3","title":"Efficacy and Safety Study of Shenwu Capsule","status":"COMPLETED","sponsor":"North China Pharmaceutical Group Corporation","startDate":"2008-09","conditions":"Mild Cognitive Impairment","enrollment":324},{"nctId":"NCT02187276","phase":"","title":"The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2009-06","conditions":"Alzheimer Disease, Late Onset","enrollment":129},{"nctId":"NCT00467389","phase":"PHASE2","title":"Use of Donepezil for Treatment of Cocaine Dependence","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2007-02","conditions":"Cocaine Abuse and Dependence","enrollment":12},{"nctId":"NCT01028911","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease","status":"TERMINATED","sponsor":"Pfizer","startDate":"2009-12","conditions":"Alzheimer's Disease","enrollment":9},{"nctId":"NCT01903824","phase":"PHASE1","title":"Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-08","conditions":"Cognitive Impairment","enrollment":40},{"nctId":"NCT00843115","phase":"","title":"Observational Study Of Donepezil In Routine Clinical Practice","status":"TERMINATED","sponsor":"Pfizer","startDate":"2007-02","conditions":"Alzheimer's Disease","enrollment":370},{"nctId":"NCT01082965","phase":"NA","title":"Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease","status":"TERMINATED","sponsor":"Pfizer","startDate":"2010-07","conditions":"Alzheimer's Disease","enrollment":18},{"nctId":"NCT01419366","phase":"PHASE1","title":"Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT00369603","phase":"PHASE4","title":"Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients","status":"TERMINATED","sponsor":"Duke University","startDate":"2006-10","conditions":"Alzheimer's Disease","enrollment":4},{"nctId":"NCT00868010","phase":"PHASE3","title":"Enhancing Rehabilitation After Stroke","status":"UNKNOWN","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2009-03","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT00177671","phase":"PHASE4","title":"Antidepressant Medication Plus Donepezil for Treating Late-life Depression","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2003-12","conditions":"Depression, Dementia","enrollment":220},{"nctId":"NCT01696591","phase":"","title":"The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD","status":"UNKNOWN","sponsor":"Duk Lyul Na","startDate":"2012-03","conditions":"Alzheimer Disease, Dementia, Brain Diseases","enrollment":14},{"nctId":"NCT00548145","phase":"NA","title":"The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease","status":"TERMINATED","sponsor":"Osaka University","startDate":"2007-11","conditions":"Alzheimer Disease, Hypercholesterolemia","enrollment":38},{"nctId":"NCT01450839","phase":"PHASE1","title":"E2022 Patch Formulation Multiple Dose Study","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2011-09","conditions":"Healthy","enrollment":16},{"nctId":"NCT01490567","phase":"PHASE4","title":"A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia","status":"UNKNOWN","sponsor":"Central South University","startDate":"2011-06","conditions":"Impaired Cognition, Schizophrenia","enrollment":80},{"nctId":"NCT01345864","phase":"PHASE1","title":"Assessment Of The Effects Of Single Doses Of An Investigational Drug, Given Alone Or With Donepezil, On Scopolamine-Induced Changes In Memory And Learning In Healthy Adults","status":"TERMINATED","sponsor":"Pfizer","startDate":"2011-05","conditions":"Healthy","enrollment":88},{"nctId":"NCT00206947","phase":"PHASE2","title":"The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia","status":"TERMINATED","sponsor":"Birte Glenthoj","startDate":"2002-12","conditions":"Schizophrenia","enrollment":50},{"nctId":"NCT01419340","phase":"PHASE1","title":"Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT01245530","phase":"PHASE3","title":"An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia","status":"COMPLETED","sponsor":"Whanin Pharmaceutical Company","startDate":"2008-06","conditions":"Alzheimer Type Dementia","enrollment":280},{"nctId":"NCT01297036","phase":"PHASE1","title":"Pharmacokinetic Comparisons of Two Donepezil Formulations","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2008-01","conditions":"Alzheimer Disease","enrollment":22},{"nctId":"NCT01042314","phase":"PHASE1","title":"Drug-Drug Interaction Study With Aricept® (Donepezil)","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2010-01","conditions":"Alzheimer Disease","enrollment":18},{"nctId":"NCT00006399","phase":"PHASE2","title":"Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease","status":"COMPLETED","sponsor":"National Center for Research Resources (NCRR)","startDate":"1999-09","conditions":"Alzheimer Disease","enrollment":45},{"nctId":"NCT00480870","phase":"PHASE4","title":"The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients","status":"COMPLETED","sponsor":"Associacao Fundo de Incentivo a Psicofarmcologia","startDate":"1999-04","conditions":"Alzheimer Disease, Sleep Apnea, Obstructive","enrollment":65}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":87,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Donepezil drug treatment","genericName":"Donepezil drug treatment","companyName":"Shanghai Jiao Tong University School of Medicine","companyId":"shanghai-jiao-tong-university-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Donepezil inhibits acetylcholinesterase, increasing acetylcholine levels in the brain to improve cognitive function in Alzheimer's disease. Used for Mild to moderate Alzheimer's disease, Mild cognitive impairment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}